Repetitive DNA sequences located in the central region of the human mdr1 (multidrug resistance) gene may account for a gene fusion event during its evolution

The mdr1 gene, first member of the human multidrug-resistance gene family, is a major gene involved in cellular resistance to several drugs used in anticancer chemotherapy. Its product, the drug-excreting P-glycoprotein, shows a bipartite structure formed by two similar adjacent halves. According to one hypothesis, the fusion of two related ancestral genes during evolution could have resulted in this structure. The DNA sequence analysis of the introns located in the region connecting the two halves of the human mdr1 gene revealed a highly conserved poly(CA) · poly (TG) sequence in intron 15 and repeated sequences of the Alu family in introns 14 and 17. These repeated sequences most likely represent molecular fossils of ancient DNA elements which were involved in such a recombination event. Correspondence to: M. Pauly     

Crystal structure and mutational analysis of a perlecan-binding fragment of nidogen-1.

Nidogen, an invariant component of basement membranes, is a multifunctional protein that interacts with most other major basement membrane proteins. Here, we report the crystal structure of the mouse nidogen-1 G2 fragment, which contains binding sites for collagen IV and perlecan. The structure is composed of an EGF-like domain and an 11-stranded beta-barrel with a central helix. The beta-barrel domain has unexpected similarity to green fluorescent protein. A large surface patch on the beta-barrel is strikingly conserved in all metazoan nidogens. Site-directed mutagenesis demonstrates that the conserved residues are involved in perlecan binding.     

CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease

Cerebrospinal fluid (CSF) biomarkers T-Tau and Aβ(42) are linked with Alzheimer's disease (AD), yet little is known about the relationship between CSF biomarkers and structural brain alteration in healthy adults. In this study we examined the extent to which AD biomarkers measured in CSF predict brain microstructure indexed by diffusion tensor imaging (DTI) and volume indexed by T1-weighted imaging. Forty-three middle-aged adults with parental family history of AD received baseline lumbar puncture and MRI approximately 3.5 years later. Voxel-wise image analysis methods were used to test whether baseline CSF Aβ(42), total tau (T-Tau), phosphorylated tau (P-Tau) and neurofilament light protein predicted brain microstructure as indexed by DTI and gray matter volume indexed by T1-weighted imaging. T-Tau and T-Tau/Aβ(42) were widely correlated with indices of brain microstructure (mean, axial, and radial diffusivity), notably in white matter regions adjacent to gray matter structures affected in the earliest stages of AD. None of the CSF biomarkers were related to gray matter volume. Elevated P-Tau and P-Tau/Aβ(42) levels were associated with lower recognition performance on the Rey Auditory Verbal Learning Test. Overall, the results suggest that CSF biomarkers are related to brain microstructure in healthy adults with elevated risk of developing AD. Furthermore, the results clearly suggest that early pathological changes in AD can be detected with DTI and occur not only in cortex, but also in white matter.     

Detergent-activated BAX Protein Is a Monomer

BAX is a pro-apoptotic member of the BCL-2 protein family. At the onset of apoptosis, monomeric, cytoplasmic BAX is activated and translocates to the outer mitochondrial membrane, where it forms an oligomeric pore. The chemical mechanism of BAX activation is controversial, and several in vitro and in vivo methods of its activation are known. One of the most commonly used in vitro methods is activation with detergents, such as n-octyl glucoside. During BAX activation with n-octyl glucoside, it has been shown that BAX forms high molecular weight complexes that are larger than the combined molecular weight of BAX monomer and one detergent micelle. These large complexes have been ascribed to the oligomerization of BAX prior to its membrane insertion and pore formation. This is in contrast to the in vivo studies that suggest that active BAX inserts into the outer mitochondrial membrane as a monomer and then undergoes oligomerization. Here, to simultaneously determine the molecular weight and the number of BAX proteins per BAX-detergent micelle during detergent activation, we have used an approach that combines two single-molecule sensitivity technique, fluorescence correlation spectroscopy, and fluorescence-intensity distribution analysis. We have tested a range of detergents as follows: n-octyl glucoside, dodecyl maltoside, Triton X-100, Tween 20, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid, and cholic acid. With these detergents we observe that BAX is a monomer before, during, and after interaction with micelles. We conclude that detergent activation of BAX is not congruent with oligomerization and that in physiologic buffer conditions BAX can assume two stable monomeric conformations, one inactive and one active.BAX² is a pro-apoptotic member of the BCL-2 protein family. In a simplified apoptosis model, monomeric inactive BAX is localized in the cytoplasm of healthy nondying cells (1). During apoptosis BAX is activated and translocates to the outer mitochondrial membrane (2) where it inserts as a monomer (3), undergoes oligomerization (4), and forms a pore through which cytochrome c and other apoptotic factors are released into the cytoplasm. Once in the cytoplasm, these apoptotic factors induce the activation of the effector caspases that execute the cell death process. This mechanism, which is generally correct, requires that soluble BAX becomes integrated into the mitochondrial membrane where it forms a functional oligomeric pore capable of cytochrome c release. However, the molecular mechanism of BAX activation remains controversial (5, 6).It has been understood for some time, but frequently ignored, that activity of the BCL-2 family proteins is exhibited in cells when these proteins are associated with the hydrophobic environment of membranes. Therefore, it has always seemed that attention to the effect of hydrophobic environments on the BCL-2 family proteins would be rewarding. It has been shown that BAX can be directly activated by treatment with nonionic detergents such as n-octyl glucoside, dodecyl maltoside, and Triton X-100 (1, 7). During activation by nonionic detergents, to gain the ability to form pores in a bilayer membrane, BAX needs to undergo a major conformational transition from a globular protein with two pore-forming α-helices 5 and 6 hidden in the protein core (8) to a conformation in which these two helices are exposed and inserted into a lipid membrane (3, 5, 9). The nature of this active conformation of BAX is important for the understanding of the death decision in cells. Most proposals suggest that in a cell this activated form of BAX protein is initiated and maintained by the interactions with other proteins, such as tBID, or by BAX itself as a homo-oligomer (7, 10).Nonionic detergents have been commonly used to activate BAX for in vitro studies because they are reliably effective and simple to employ. However, little is known about the detailed molecular mechanism of BAX activation by these detergents and its comparability with in vivo activation of BAX. What is known is that concentrations of detergent above their critical micelle concentration (CMC) are necessary for BAX activation. This suggests that, to be activated, BAX needs to interact with detergent micelles instead of monomeric detergent molecules. For example, in the case of BAX activation by n-octyl glucoside, it has been shown that n-octyl glucoside concentration should be 1% (w/v) (7), which is well above the CMC for this detergent (0.6% w/v) (11). In addition, it has also been shown that above their individual CMC concentrations most BAX-activating detergents produce a change in BAX conformation that can be detected by a conformation-sensitive 6A7 antibody against BAX (1, 12, 13). In cellular experiments this feature of BAX reactivity to 6A7 antibody is commonly associated with the onset of apoptosis (14, 15). However, CHAPS does not generate the antibody-detected conformational change or the activation of BAX. The small micelle size of this detergent (10 kDa) suggests that perhaps BAX cannot adopt an activated state with this detergent. However, cholic acid with even smaller micelle size (4 kDa) can partially activate BAX (1).Many important detergent properties are associated with micelles. The formation of detergent micelles in solution is concentration-dependent beginning at the CMC. The CMC value for a detergent has practical importance because in most cases only monomers of detergent can be removed by dialysis, and therefore, it is easier to remove detergent monomers for a detergent with high CMC value than for a detergent with low CMC (11). For BAX this same consideration applies to its activation with n-octyl glucoside (CMC ∼23 mm) as compared with its activation with Triton X-100 (CMC ∼0.25 mm). The ease of dialysis is why, in most cases, OG is used to activate BAX in vitro.It has been shown by analytical gel filtration that, when incubated with n-octyl glucoside, BAX creates complexes with molecular weight larger than the combined size of a BAX monomer (21 kDa) and an n-octyl glucoside micelle (∼26 kDa) (7, 11). It has also been shown that in defined liposomes BAX pore formation requires oligomerization (16). These data combined with the knowledge that oligomerization is important for the biological function of BAX led to a hypothesis that BAX oligomerizes during its detergent activation prior to membrane insertion (7). However, it has been shown that in vivo activated BAX inserts into the outer mitochondrial membrane as a monomer (3), and to create a pore, BAX undergoes oligomerization in this membrane (4). This discrepancy between the oligomeric state of active BAX prior to its insertion into a lipid membrane in vivo (monomer) and in vitro (possibly hexamer or octamer) led us to study the oligomerization state of BAX in detergent micelles. The important issue is whether BAX activation requires protein oligomerization or whether active BAX conformation can be generated from a single protein monomer. To solve this issue we used two single-molecule sensitivity techniques: fluorescence correlation spectroscopy (FCS) (17) and fluorescence-intensity distribution analysis (FIDA) (18). Combined use of FCS and FIDA allows simultaneous determination of the apparent molecular weight and the number of fluorescently labeled BAX monomers per protein-detergent micelle. Our results are consistent with previously established results in which BAX forms high molecular weight protein-detergent micelles with n-octyl glucoside (4) and show that BAX is present as a monomer in these complexes. In addition, we determined the apparent molecular weight and the number of BAX proteins bound per protein-detergent micelles formed by BAX and micelles of five additional detergents (dodecyl maltoside, Triton X-100, Tween 20, cholic acid, and CHAPS). Our data show that BAX is a monomer before, during, and after interaction with the micelles of all tested detergents.     

A Branched Biosynthetic Pathway Is Involved in Production of Roquefortine and Related Compounds in Penicillium chrysogenum

Profiling and structural elucidation of secondary metabolites produced by the filamentous fungus Penicillium chrysogenum and derived deletion strains were used to identify the various metabolites and enzymatic steps belonging to the roquefortine/meleagrin pathway. Major abundant metabolites of this pathway were identified as histidyltryptophanyldiketopiperazine (HTD), dehydrohistidyltryptophanyldi-ketopiperazine (DHTD), roquefortine D, roquefortine C, glandicoline A, glandicoline B and meleagrin. Specific genes could be assigned to each enzymatic reaction step. The nonribosomal peptide synthetase RoqA accepts L-histidine and L-tryptophan as substrates leading to the production of the diketopiperazine HTD. DHTD, previously suggested to be a degradation product of roquefortine C, was found to be derived from HTD involving the cytochrome P450 oxidoreductase RoqR. The dimethylallyltryptophan synthetase RoqD prenylates both HTD and DHTD yielding directly the products roquefortine D and roquefortine C without the synthesis of a previously suggested intermediate and the involvement of RoqM. This leads to a branch in the otherwise linear pathway. Roquefortine C is subsequently converted into glandicoline B with glandicoline A as intermediates, involving two monooxygenases (RoqM and RoqO) which were mixed up in an earlier attempt to elucidate the biosynthetic pathway. Eventually, meleagrin is produced from glandicoline B involving a methyltransferase (RoqN). It is concluded that roquefortine C and meleagrin are derived from a branched biosynthetic pathway.